• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去铁酮有效抑制铜催化产生羟自由基。

Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone.

机构信息

V. A. Institute of Chemical Kinetics and Combustion, Institutskaya Str., 3, Novosibirsk, 630090, Russia.

Novosibirsk State University, Pirogova Str., 2, 630090, Novosibirsk, Russia.

出版信息

J Biol Inorg Chem. 2019 May;24(3):331-341. doi: 10.1007/s00775-019-01650-9. Epub 2019 Mar 13.

DOI:10.1007/s00775-019-01650-9
PMID:30868263
Abstract

Copper ions can catalyze the production of free oxygen radicals (•OH and •OOH) similar to iron ions. The capacity to initiate oxidative damage is most commonly attributed to Cu-induced toxicity in copper-related diseases where there is an increase in copper levels and also when Cu homeostasis and regulation are disrupted. An antioxidant/chelator inhibiting Cu-induced oxidative damage could play a significant role in the treatment of such Cu-related diseases. Deferiprone has high affinity for copper binding and can be considered for the potential treatment of copper toxicity and overloading conditions, such as Wilson's disease. In the present study, the ability of deferiprone to inhibit the production of hydroxyl radicals catalyzed by copper ions was elucidated using an Electron Paramagnetic Resonance (EPR) spin trapping technique. The values of g-factors and hyperfine splitting constants were calculated for Cu(II)-deferiprone 1:1 complex: (a = 58.5 G, g = 2.1667) and 1:2 complex: (a = 73.0 G, g = 2.1378). The TMIO spin trap (2,2,4-trimethyl-2H-imidazole-1-oxide) was used for the detection of free radicals formed in Fenton-like copper-catalyzed reactions. It was demonstrated that the interaction of deferiprone with Cu ions completely inhibited hydroxyl radical (•OH) production in the presence of hydrogen peroxide. It was found also that deferiprone inhibits Cu-induced oxidation of linoleic acid in micellar solution. In addition to existing data for water solutions, the affinity of deferiprone for copper binding in non-aqueous environment has been elucidated.

摘要

铜离子可以像铁离子一样催化游离氧自由基(•OH 和•OOH)的生成。铜诱导毒性的能力通常归因于铜相关疾病中铜水平的增加,以及当铜的动态平衡和调节被破坏时。一种能够抑制铜诱导氧化损伤的抗氧化剂/螯合剂,可能在治疗这种铜相关疾病方面发挥重要作用。去铁酮对铜结合具有高亲和力,可考虑用于治疗铜毒性和超负荷情况,如威尔逊氏病。在本研究中,使用电子顺磁共振(EPR)自旋捕获技术阐明了去铁酮抑制铜离子催化羟基自由基生成的能力。计算了 Cu(II)-去铁酮 1:1 配合物的 g 因子和超精细分裂常数:(a = 58.5 G,g = 2.1667)和 1:2 配合物:(a = 73.0 G,g = 2.1378)。TMIO 自旋捕获剂(2,2,4-三甲基-2H-咪唑-1-氧化物)用于检测 Fenton 样铜催化反应中形成的自由基。结果表明,去铁酮与铜离子的相互作用在存在过氧化氢的情况下完全抑制了羟基自由基(•OH)的生成。还发现去铁酮抑制了铜诱导的胶束溶液中亚油酸的氧化。除了现有的水溶液数据外,还阐明了去铁酮在非水环境中与铜结合的亲和力。

相似文献

1
Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone.去铁酮有效抑制铜催化产生羟自由基。
J Biol Inorg Chem. 2019 May;24(3):331-341. doi: 10.1007/s00775-019-01650-9. Epub 2019 Mar 13.
2
Inhibition of Fe(2+)- and Fe(3+)- induced hydroxyl radical production by the iron-chelating drug deferiprone.去铁酮抑制铁离子诱导的羟自由基生成。
Free Radic Biol Med. 2015 Jan;78:118-22. doi: 10.1016/j.freeradbiomed.2014.10.513. Epub 2014 Oct 29.
3
The role of chelating agents and amino acids in preventing free radical formation in bleaching systems.螯合剂和氨基酸在预防漂白系统中自由基形成中的作用。
Free Radic Biol Med. 2018 Dec;129:194-201. doi: 10.1016/j.freeradbiomed.2018.09.023. Epub 2018 Sep 19.
4
Redox Interactions of Vitamin C and Iron: Inhibition of the Pro-Oxidant Activity by Deferiprone.维生素 C 和铁的氧化还原相互作用:去铁酮抑制其促氧化剂活性。
Int J Mol Sci. 2020 May 31;21(11):3967. doi: 10.3390/ijms21113967.
5
Direct evidence for inhibition of free radical formation from Cu(I) and hydrogen peroxide by glutathione and other potential ligands using the EPR spin-trapping technique.使用电子顺磁共振自旋捕获技术,获得了谷胱甘肽和其他潜在配体抑制铜(I)和过氧化氢形成自由基的直接证据。
Arch Biochem Biophys. 1992 May 15;295(1):205-13. doi: 10.1016/0003-9861(92)90507-s.
6
Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.吡哆醛异烟酰腙(PIH)可防止铜介导的体外自由基形成。
Mol Cell Biochem. 2001 Dec;228(1-2):73-82. doi: 10.1023/a:1013348005312.
7
Superoxide dismutase-like activities of copper(II) complexes tested in serum.在血清中测试的铜(II)配合物的超氧化物歧化酶样活性。
Biochim Biophys Acta. 1987 Sep 24;915(2):267-76. doi: 10.1016/0167-4838(87)90309-8.
8
Reactions of captopril and epicaptopril with transition metal ions and hydroxyl radicals: an EPR spectroscopy study.卡托普利和依那普利拉与过渡金属离子及羟基自由基的反应:一项电子顺磁共振波谱研究
Free Radic Biol Med. 1993 Dec;15(6):611-9. doi: 10.1016/0891-5849(93)90164-p.
9
The role of redox active copper(II) on antioxidant properties of the flavonoid baicalein: DNA protection under Cu(II)-Fenton reaction and Cu(II)-ascorbate system conditions.氧化还原活性铜(II)对黄酮类化合物黄芩素抗氧化性能的作用:Cu(II)-Fenton 反应和 Cu(II)-抗坏血酸体系条件下的 DNA 保护。
J Inorg Biochem. 2023 Aug;245:112244. doi: 10.1016/j.jinorgbio.2023.112244. Epub 2023 May 4.
10
The fenton activity of iron(III) in the presence of deferiprone.去铁酮存在下铁(III)的芬顿活性
J Pharm Sci. 2008 Apr;97(4):1454-67. doi: 10.1002/jps.21039.

引用本文的文献

1
Novel Anthraquinone Derivatives and Their Complexes with Metal Ions with Anticancer Activity: Structure/Redox and Chelation Activity Correlations.具有抗癌活性的新型蒽醌衍生物及其与金属离子的配合物:结构/氧化还原与螯合活性的相关性
Pharmaceuticals (Basel). 2024 Dec 19;17(12):1717. doi: 10.3390/ph17121717.
2
Novel insights into cuproptosis inducers and inhibitors.对铜死亡诱导剂和抑制剂的新见解。
Front Mol Biosci. 2024 Nov 26;11:1477971. doi: 10.3389/fmolb.2024.1477971. eCollection 2024.
3
Metal Complexes of Omadine (-Hydroxypyridine-2-thione): Differences of Antioxidant and Pro-Oxidant Behavior in Light and Dark Conditions with Possible Toxicity Implications.

本文引用的文献

1
Copper(II) complexes with Fusobacterium nucleatum adhesin FadA: Coordination pattern, physicochemical properties and reactivity.铜(II)配合物与具核梭杆菌黏附素 FadA:配位模式、物理化学性质和反应性。
J Inorg Biochem. 2018 Dec;189:69-80. doi: 10.1016/j.jinorgbio.2018.09.012. Epub 2018 Sep 18.
2
Redox-Active Quinone Chelators: Properties, Mechanisms of Action, Cell Delivery, and Cell Toxicity.氧化还原活性醌螯合剂:性质、作用机制、细胞递送和细胞毒性。
Antioxid Redox Signal. 2018 May 20;28(15):1394-1403. doi: 10.1089/ars.2017.7406. Epub 2018 Jan 3.
3
Protective role of quercetin against copper(II)-induced oxidative stress: A spectroscopic, theoretical and DNA damage study.
奥马汀(-羟基吡啶-2-硫酮)金属配合物:在光照和黑暗条件下抗氧化和促氧化行为的差异及其可能的毒性意义。
Molecules. 2023 May 20;28(10):4210. doi: 10.3390/molecules28104210.
4
Differential Effects of Histidine and Histidinamide versus Cysteine and Cysteinamide on Copper Ion-Induced Oxidative Stress and Cytotoxicity in HaCaT Keratinocytes.组氨酸和组氨酰胺与半胱氨酸和半胱氨酰胺对铜离子诱导的HaCaT角质形成细胞氧化应激和细胞毒性的差异影响
Antioxidants (Basel). 2023 Mar 25;12(4):801. doi: 10.3390/antiox12040801.
5
New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.新型铁代谢途径和螯合靶向策略影响各种类型和阶段癌症的治疗。
Int J Mol Sci. 2022 Nov 13;23(22):13990. doi: 10.3390/ijms232213990.
6
The Interplay of Ascorbic Acid with Quinones-Chelators-Influence on Lipid Peroxidation: Insight into Anticancer Activity.抗坏血酸与醌类螯合剂的相互作用——对脂质过氧化的影响:对抗癌活性的深入了解
Antioxidants (Basel). 2022 Feb 13;11(2):376. doi: 10.3390/antiox11020376.
7
Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.具有必需过渡金属的螯合物配合物的作用机制研究:抗氧化/促氧化活性及其在医学中的应用。
Int J Mol Sci. 2022 Jan 23;23(3):1247. doi: 10.3390/ijms23031247.
8
Antioxidant Activity of Deferasirox and Its Metal Complexes in Model Systems of Oxidative Damage: Comparison with Deferiprone.地拉罗司及其金属配合物在氧化损伤模型系统中的抗氧化活性:与去铁酮的比较。
Molecules. 2021 Aug 20;26(16):5064. doi: 10.3390/molecules26165064.
9
Cyanobacterial Harmful Algal Blooms in Aquatic Ecosystems: A Comprehensive Outlook on Current and Emerging Mitigation and Control Approaches.水生生态系统中的蓝藻有害藻华:当前及新兴缓解与控制方法的综合展望
Microorganisms. 2021 Jul 9;9(7):1472. doi: 10.3390/microorganisms9071472.
10
Solubility, Permeability, Anti-Inflammatory Action and In Vivo Pharmacokinetic Properties of Several Mechanochemically Obtained Pharmaceutical Solid Dispersions of Nimesulide.尼美舒利几种机械化学法制备的药用固体分散体的溶解度、渗透性、抗炎作用和体内药代动力学性质。
Molecules. 2021 Mar 10;26(6):1513. doi: 10.3390/molecules26061513.
槲皮素对铜(II)诱导的氧化应激的保护作用:光谱、理论及DNA损伤研究
Food Chem Toxicol. 2017 Dec;110:340-350. doi: 10.1016/j.fct.2017.10.042. Epub 2017 Oct 26.
4
Lipid peroxidation in cell death.细胞死亡中的脂质过氧化作用。
Biochem Biophys Res Commun. 2017 Jan 15;482(3):419-425. doi: 10.1016/j.bbrc.2016.10.086. Epub 2017 Feb 3.
5
The enhancement of oxidative DNA damage by anti-diabetic metformin, buformin, and phenformin, via nitrogen-centered radicals.抗糖尿病药物二甲双胍、苯乙双胍和苯福明通过氮中心自由基增强氧化性DNA损伤。
Free Radic Res. 2016 Aug;50(8):929-37. doi: 10.1080/10715762.2016.1204651.
6
Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid molecules.利用多功能他克林-香豆素杂合分子靶向阿尔茨海默病中铜(II)诱导的氧化应激和乙酰胆碱酯酶系统。
J Inorg Biochem. 2016 Aug;161:52-62. doi: 10.1016/j.jinorgbio.2016.05.001. Epub 2016 May 5.
7
Effective ascorbate-free and photolatent click reactions in water using a photoreducible copper(II)-ethylenediamine precatalyst.使用可光还原的铜(II)-乙二胺预催化剂在水中进行有效的无抗坏血酸和光潜性点击反应。
Beilstein J Org Chem. 2015 Oct 21;11:1950-9. doi: 10.3762/bjoc.11.211. eCollection 2015.
8
Impact of Cu(2+) ions on the structure of colistin and cell-free system nucleic acid degradation.铜离子(Cu(2+))对多粘菌素结构及无细胞系统核酸降解的影响
J Inorg Biochem. 2015 Oct;151:67-74. doi: 10.1016/j.jinorgbio.2015.05.011. Epub 2015 May 27.
9
Spin trapping combined with quantitative mass spectrometry defines free radical redistribution within the oxidized hemoglobin:haptoglobin complex.自旋捕获结合定量质谱分析定义了氧化血红蛋白:触珠蛋白复合物内自由基的重新分布。
Free Radic Biol Med. 2015 Aug;85:259-68. doi: 10.1016/j.freeradbiomed.2015.04.023. Epub 2015 Apr 28.
10
Synthesis, crystal structure, spectroscopic properties and potential biological activities of salicylate‒neocuproine ternary copper(II) complexes.水杨酸盐-新铜试剂三元铜(II)配合物的合成、晶体结构、光谱性质及潜在生物活性
Molecules. 2015 Jan 27;20(2):2115-37. doi: 10.3390/molecules20022115.